Business Description
Godavari Drugs Ltd
ISIN : INE362C01012
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | 2.99 | |||||
Interest Coverage | 3.15 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.05 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.6 | |||||
3-Year EBITDA Growth Rate | 21.7 | |||||
3-Year Book Growth Rate | 13.5 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.37 | |||||
9-Day RSI | 35.96 | |||||
14-Day RSI | 42 | |||||
6-1 Month Momentum % | 9.74 | |||||
12-1 Month Momentum % | 29.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 63 | |||||
Days Sales Outstanding | 142.02 | |||||
Days Payable | 146.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -8.98 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.53 | |||||
Operating Margin % | 7.39 | |||||
Net Margin % | 2.71 | |||||
FCF Margin % | 2.52 | |||||
ROE % | 13.16 | |||||
ROA % | 3.4 | |||||
ROIC % | 11.8 | |||||
ROC (Joel Greenblatt) % | 14.05 | |||||
ROCE % | 19.76 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.63 | |||||
PE Ratio without NRI | 266.58 | |||||
Shiller PE Ratio | 21.79 | |||||
Price-to-Owner-Earnings | 13.97 | |||||
PEG Ratio | 11.11 | |||||
PS Ratio | 0.47 | |||||
PB Ratio | 2.13 | |||||
Price-to-Tangible-Book | 2.08 | |||||
Price-to-Free-Cash-Flow | 18.99 | |||||
Price-to-Operating-Cash-Flow | 5.63 | |||||
EV-to-EBIT | 11.16 | |||||
EV-to-EBITDA | 9.23 | |||||
EV-to-Revenue | 0.66 | |||||
EV-to-FCF | 27.17 | |||||
Price-to-Projected-FCF | 1.51 | |||||
Price-to-DCF (Earnings Based) | 28.14 | |||||
Price-to-DCF (FCF Based) | 2 | |||||
Price-to-Median-PS-Value | 1.22 | |||||
Price-to-Peter-Lynch-Fair-Value | 13.97 | |||||
Price-to-Graham-Number | 4.91 | |||||
Earnings Yield (Greenblatt) % | 8.96 | |||||
FCF Yield % | 5.39 | |||||
Forward Rate of Return (Yacktman) % | 22.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Godavari Drugs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1,554.415 | ||
EPS (TTM) (₹) | 5.61 | ||
Beta | 0.51 | ||
Volatility % | 31.35 | ||
14-Day RSI | 42 | ||
14-Day ATR (₹) | 4.220349 | ||
20-Day SMA (₹) | 99.257 | ||
12-1 Month Momentum % | 29.93 | ||
52-Week Range (₹) | 76.8 - 114 | ||
Shares Outstanding (Mil) | 7.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Godavari Drugs Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Godavari Drugs Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Godavari Drugs Ltd Frequently Asked Questions
What is Godavari Drugs Ltd(BOM:530317)'s stock price today?
When is next earnings date of Godavari Drugs Ltd(BOM:530317)?
Does Godavari Drugs Ltd(BOM:530317) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |